PAG
IBRX icon

Private Advisor Group’s ImmunityBio IBRX Stock Holding History

Private Advisor Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
165,954
-1,482,602
-90% -$11.2M 0.01% 1171
2026
Q1 		$12.6M Buy
1,648,556
+1,487,482
+923% +$10.2M 0.06% 340
2025
Q4 		$319K Buy
161,074
+148,222
+1,153% +$336K ﹤0.01% 2116
2025
Q3 		$31.6K Sell
12,852
-203
-2% -$523 ﹤0.01% 2479
2025
Q2 		$34.5K Buy
13,055
+203
+2% +$546 ﹤0.01% 2370
2025
Q1 		$38.7K Sell
12,852
-598
-4% -$1.81K ﹤0.01% 2247
2024
Q4 		$34.4K Sell
13,450
-41,317
-75% -$172K ﹤0.01% 2227
2024
Q3 		$204K Sell
54,767
-32,140
-37% -$149K ﹤0.01% 2205
2024
Q2 		$549K Buy
86,907
+76,407
+728% +$504K ﹤0.01% 1512
2024
Q1 		$56.4K Hold
10,500
– – ﹤0.01% 2238
2023
Q4 		$52.7K Buy
+10,500
New +$32.9K ﹤0.01% 2159
2020
Q3 		– Sell
-500
Closed -$6K – 2450
2020
Q2 		$6K Buy
+500
New +$2.82K ﹤0.01% 3163

Other funds holding IBRX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
KA
Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
LCGC
Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Private Advisor Group's IBRX Position: Q2 2026 in Review

Private Advisor Group reduced its ImmunityBio (IBRX) stake by 90% in Q2 2026, selling an estimated $11.2M and leaving 165,954 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #1171.

Private Advisor Group first reported a position in IBRX in Q2 2020 and has held it in 12 quarters since. The position peaked at $12.6M in Q1 2026. 133 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Private Advisor Group held 165,954 shares of ImmunityBio worth $1.45M as of Q2 2026.
  • Private Advisor Group sold 1,482,602 ImmunityBio shares in Q2 2026, an estimated $11.2M.
  • ImmunityBio made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1171 holding.
  • Private Advisor Group first reported a position in ImmunityBio in Q2 2020 and has held it in 12 quarters since.
  • Private Advisor Group's ImmunityBio position peaked at $12.6M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.